SeaStar Medical Provided Updates on Enrollment of Adult Pivotal Clinical Study and Commercial Launch of Quelimmune, FDA-Approved in Pediatric Patients

  • Kevin Chung

Press/Media

Period14 Mar 2024

Media coverage

1

Media coverage

  • TitleSeaStar Medical Provided Updates on Enrollment of Adult Pivotal Clinical Study and Commercial Launch of Quelimmune, FDA-Approved in Pediatric Patients
    Media name/outletImpact Financial News
    Country/TerritoryUnited Kingdom
    Date14/03/24
    PersonsKevin Chung